hepatitis a vaccine, inactivated (vaqta) Report issue

Active Ingredient History

  • Now
Hepatitis A vaccine is a vaccine that prevents hepatitis A. It is effective in around 95% of cases and lasts for at least twenty years and possibly a person's entire life. If given, two doses are recommended beginning after the age of one. It is given by injection into a muscle. The first hepatitis A vaccine was approved in Europe in 1991, and the United States in 1995. It is on the World Health Organization's List of Essential Medicines.   Wikipedia

More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data
avaxim | havrix | healive | hepatitis a-b vaccine | hepatitis a (control) | hepatitis a inactivated virus vaccine | hepatitis a vaccine | hepatitis a vaccine, inactivated | hepatitis a vaccine, inactivated, nuclease purified | hepatitis a virus vaccine | hepatits a vaccine | inactivated hav vaccine, lu8 strain | inactivated hav vaccine, tz84 strain | inactivated hepatitis a vaccine | inactivated hep a vaccine | twinrix | vaqta


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue